<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)</article-title>
</title-group>
